Karo Pharma AB (publ)

LSE:0RAQ Stock Report

Market Cap: SEK 16.6b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Karo Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0RAQ?
Owner TypeNumber of SharesOwnership Percentage
Institutions15,063,5265.51%
General Public78,355,81028.7%
VC/PE Firms179,835,26865.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.4%.

Top Shareholders

Top 25 shareholders own 71.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
65.8%
EQT Partners AB
179,835,268SEK 10.9b0%10.89%
1.06%
Avanza Fonder AB
2,896,660SEK 175.8m0%0.44%
0.95%
State Street Global Advisors, Inc.
2,599,955SEK 157.8m0%no data
0.65%
SIX Group AG, Asset Management Arm
1,783,735SEK 108.3m0%0.8%
0.5%
Norges Bank Investment Management
1,374,087SEK 83.4m0%no data
0.49%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
1,348,014SEK 81.8m0%no data
0.48%
SEB Investment Management AB
1,320,482SEK 80.2m0%0.02%
0.47%
Goldman Sachs Group, Investment Banking and Securities Investments
1,288,230SEK 78.2m0%no data
0.35%
Livforsakringsaktiebolaget Skandia AB, Asset Management Arm
968,640SEK 58.8m0%0.51%
0.34%
Xact Kapitalförvaltning AB
937,208SEK 56.9m0%0.04%
0.046%
SPP Fonder AB
125,205SEK 7.6m0%no data
0.028%
FCG Fonder AB
77,603SEK 4.7m0%0.19%
0.026%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
71,304SEK 4.3m0%no data
0.021%
UBS Asset Management
56,825SEK 3.5m0%no data
0.016%
Deutsche Asset & Wealth Management
43,799SEK 2.7m0%no data
0.011%
Eaton Vance Management
29,600SEK 1.8m0%no data
0.0098%
Dimensional Fund Advisors LP
26,918SEK 1.6m0%no data
0.0075%
Geode Capital Management, LLC
20,518SEK 1.2m-0.46%no data
0.007%
Catella FondfÖRvaltning Ab
19,188SEK 1.2m0%0.02%
0.0066%
The Vanguard Group, Inc.
18,170SEK 1.1m-67.9%no data
0.0047%
Fundlogic SAS
12,829SEK 777.9k0%no data
0.0043%
QI Investment Advisory GmbH
11,621SEK 704.9k0%0.4%
0.0037%
Hussman Strategic Advisors Inc
10,000SEK 607.1k0%0.01%
0.0034%
Mercer Global Investments Europe Limited
9,350SEK 567.3k0%no data
0.0033%
KLP Kapitalforvaltning AS
9,101SEK 552.3k-54.8%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/25 13:41
End of Day Share Price 2022/11/24 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Karo Pharma AB (publ) is covered by 5 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander LindströmABG Sundal Collier
Camilla OxhamreCarnegie Investment Bank AB
Mats LissKepler Cheuvreux